Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Strunk

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
European Journal of Heart Failure|February 5, 2009
Prognostic value of plasma midregional pro-adrenomedullin and C-terminal-pro-endothelin-1 in chronic heart failure outpatientsChristopher Adlbrecht, Martin Hülsmann, Guido Strunk, et al.
Clinical Chemistry|October 21, 2016
GDF-15 Is Associated with Cancer Incidence in Patients with Type 2 DiabetesNoemi Pavo, Raphael Wurm, Stephanie Neuhold, et al.
Scientific Reports|February 24, 2019
The circulating form of neprilysin is not a general biomarker for overall survival in treatment-naïve cancer patientsNoemi Pavo, Henrike Arfsten, Anna Cho, et al.
European Heart Journal|August 15, 2008
Chronic heart failure leads to an expanded plasma volume and pseudoanaemia, but does not lead to a reduction in the body's red cell volumeChristopher Adlbrecht, Spyridoula Kommata, Martin Hülsmann, et al.
JACC. Cardiovascular Imaging|January 21, 2019
Natural History of Functional Tricuspid Regurgitation: Implications of Quantitative Doppler AssessmentPhilipp E Bartko, Henrike Arfsten, Maria K Frey, et al.
European Journal of Heart Failure|March 24, 2020
Increased resting heart rate and prognosis in treatment-naïve unselected cancer patients: results from a prospective observational studyMarkus S Anker, Maria K Frey, Georg Goliasch, et al.
Biomedicines|August 28, 2025
Implementation of Medical Therapy in Different Stages of Heart Failure with Reduced Ejection Fraction: An Analysis of the VIENNA-HF RegistryNoel G Panagiotides, Annika Weidenhammer, Suriya Prausmüller, et al.
European Heart Journal. Cardiovascular Imaging|April 25, 2022
Guideline directed medical therapy and reduction of secondary mitral regurgitationGeorg Spinka, Philipp E Bartko, Gregor Heitzinger, et al.
Journal of Psychopathology and Clinical Science|October 16, 2023
The best of both worlds? General principles of psychopathology in personalized assessmentMerlijn Olthof, Fred Hasselman, Benjamin Aas, et al.
European Journal of Preventive Cardiology|May 21, 2023
Obesity in heart failure with preserved ejection fraction with and without diabetes: risk factor or innocent bystander?Suriya Prausmüller, Annika Weidenhammer, Gregor Heitzinger, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
European Journal of Heart Failure|February 5, 2009
Prognostic value of plasma midregional pro-adrenomedullin and C-terminal-pro-endothelin-1 in chronic heart failure outpatientsChristopher Adlbrecht, Martin Hülsmann, Guido Strunk, et al.
Clinical Chemistry|October 21, 2016
GDF-15 Is Associated with Cancer Incidence in Patients with Type 2 DiabetesNoemi Pavo, Raphael Wurm, Stephanie Neuhold, et al.
Scientific Reports|February 24, 2019
The circulating form of neprilysin is not a general biomarker for overall survival in treatment-naïve cancer patientsNoemi Pavo, Henrike Arfsten, Anna Cho, et al.
European Heart Journal|August 15, 2008
Chronic heart failure leads to an expanded plasma volume and pseudoanaemia, but does not lead to a reduction in the body's red cell volumeChristopher Adlbrecht, Spyridoula Kommata, Martin Hülsmann, et al.
JACC. Cardiovascular Imaging|January 21, 2019
Natural History of Functional Tricuspid Regurgitation: Implications of Quantitative Doppler AssessmentPhilipp E Bartko, Henrike Arfsten, Maria K Frey, et al.
European Journal of Heart Failure|March 24, 2020
Increased resting heart rate and prognosis in treatment-naïve unselected cancer patients: results from a prospective observational studyMarkus S Anker, Maria K Frey, Georg Goliasch, et al.
Biomedicines|August 28, 2025
Implementation of Medical Therapy in Different Stages of Heart Failure with Reduced Ejection Fraction: An Analysis of the VIENNA-HF RegistryNoel G Panagiotides, Annika Weidenhammer, Suriya Prausmüller, et al.
European Heart Journal. Cardiovascular Imaging|April 25, 2022
Guideline directed medical therapy and reduction of secondary mitral regurgitationGeorg Spinka, Philipp E Bartko, Gregor Heitzinger, et al.
Journal of Psychopathology and Clinical Science|October 16, 2023
The best of both worlds? General principles of psychopathology in personalized assessmentMerlijn Olthof, Fred Hasselman, Benjamin Aas, et al.
European Journal of Preventive Cardiology|May 21, 2023
Obesity in heart failure with preserved ejection fraction with and without diabetes: risk factor or innocent bystander?Suriya Prausmüller, Annika Weidenhammer, Gregor Heitzinger, et al.
Pageof 8